Ann M. Hanly, EVP & Chief Technology Officer at Vir Biotechnology, Inc. (VIR), sold 2,711 shares at $10.05 ($27K) on 2024-04-01, disclosed to the SEC on 2024-04-02.
Open-market sale of $27k VIR by EVP & Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2023-03-31 | $120K | — | Filing → |
| VIR | SELL | 2023-02-24 | $120K | — | Filing → |
| VIR | SELL | 2022-03-31 | $138K | — | Filing → |